Mozambique
2 Vaccines Approved for Use in Mozambique
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: allafrica.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: herald.co.zw
2 in Clinical Trials in Mozambique
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries